Literature DB >> 8503009

A nonpeptidyl growth hormone secretagogue.

R G Smith1, K Cheng, W R Schoen, S S Pong, G Hickey, T Jacks, B Butler, W W Chan, L Y Chaung, F Judith.   

Abstract

A nonpeptidyl secretagogue for growth hormone of the structure 3-amino-3-methyl-N-(2,3,4,5-tetrahydro-2-oxo-1-([2'-(1H-tetrazol-5 -yl) (1,1'-biphenyl)-4-yl]methyl)-1H-1-benzazepin-3(R)-yl)-butanamid e (L-692,429) has been identified. L-692,429 synergizes with the natural growth hormone secretagogue growth hormone-releasing hormone and acts through an alternative signal transduction pathway. The mechanism of action of L-692,429 and studies with peptidyl and nonpeptidyl antagonists suggest that this molecule is a mimic of the growth hormone-releasing hexapeptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6). L-692,429 is an example of a nonpeptidyl specific secretagogue for growth hormone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503009     DOI: 10.1126/science.8503009

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Current topics in GH secretagogue research--introduction.

Authors:  Barry B Bercu; Richard F Walker
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.633

2.  Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys3]-GHRP-6.

Authors:  Michelle L Maugham; Inge Seim; Patrick B Thomas; Gabrielle J Crisp; Esha T Shah; Adrian C Herington; Laura S Gregory; Colleen C Nelson; Penny L Jeffery; Lisa K Chopin
Journal:  Endocrine       Date:  2018-11-02       Impact factor: 3.633

3.  Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.

Authors:  L C Pan; P A Carpino; B A Lefker; J A Ragan; S M Toler; J C Pettersen; D O Nettleton; O Ng; C M Pirie; K Chidsey-Frink; B Lu; D F Nickerson; D A Tess; M A Mullins; D B MacLean; P A DaSilva-Jardine; D D Thompson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

4.  Synthetic growth hormone secretagogues control growth hormone secretion in the chicken at pituitary and hypothalamic levels.

Authors:  K L Geris; G J Hickey; A Vanderghote; E R Kühn; V M Darras
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

5.  The subfornical organ: a central target for circulating feeding signals.

Authors:  Katherine J Pulman; W Mark Fry; G Trevor Cottrell; Alastair V Ferguson
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

6.  Structure-lipophilicity relationships of peptides and peptidomimetics.

Authors:  N El Tayar; H Karajiannis; H van de Waterbeemd
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

7.  Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation.

Authors:  R S McDowell; K A Elias; M S Stanley; D J Burdick; J P Burnier; K S Chan; W J Fairbrother; R G Hammonds; G S Ingle; N E Jacobsen; D L Mortensen; T E Rawson; W B Won; R G Clark; T C Somers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

9.  GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.

Authors:  M R A Martins; A C A R Pinto; E Brunner; M R D Silva; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

10.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.

Authors:  Yuxiang Sun; Pei Wang; Hui Zheng; Roy G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.